We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$69.4B
AUM Growth
+$2.93B
(+4.4%)
Cap. Flow
-$611M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
44.49%
Holding
2,836
New
350
Increased
1,175
Reduced
974
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$195M |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$144M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$113M |
| 4 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$83.6M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$76.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$172M |
| 2 |
Avantis US Equity ETF
AVUS
|
+$132M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$125M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$77.3M |
| 5 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.74% |
| 2 | Financials | 2.81% |
| 3 | Healthcare | 1.59% |
| 4 | Consumer Discretionary | 1.56% |
| 5 | Consumer Staples | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Jazz Pharmaceuticals
JAZZ
$15.9B
| $220K | ﹤0.01% |
1,502
-375
| -20% | -$55.5K |
|
2052
RLX Technology
RLX
$2.48B
| $220K | ﹤0.01% |
75,774
-2,979
| -4% | -$7.22K |
|
2053
Concentrix
CNXC
$1.36B
| $219K | ﹤0.01% |
1,803
-135
| -7% | -$18.3K |
|
2054
iShares MSCI Brazil ETF
EWZ
$9.05B
| $219K | ﹤0.01% |
7,997
-12,476
| -61% | -$350K |
|
2055
NewMarket
NEU
$7.17B
| $218K | ﹤0.01% |
+598
| New | +$207K |
|
2056
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$511M
| $218K | ﹤0.01% |
4,274
+1
| +0% | +$50 |
|
|
SRCL
2057
DELISTED
Stericycle Inc
SRCL
| $218K | ﹤0.01% |
4,997
+662
| +15% | +$32.8K |
|
2058
SPX Corp
SPXC
$11B
| $218K | ﹤0.01% |
+3,087
| New | +$219K |
|
|
BTX
2059
BlackRock Technology and Private Equity Term Trust
BTX
$957M
| $218K | ﹤0.01% |
27,130
+709
| +3% | +$5.28K |
|
2060
Vishay Intertechnology
VSH
$5.86B
| $218K | ﹤0.01% |
9,621
-718
| -7% | -$15.8K |
|
2061
Amkor Technology
AMKR
$16.1B
| $217K | ﹤0.01% |
+8,357
| New | +$229K |
|
2062
CNA Financial
CNA
$14.5B
| $217K | ﹤0.01% |
+5,566
| New | +$233K |
|
2063
Aemetis
AMTX
$119M
| $217K | ﹤0.01% |
93,623
+26,693
| +40% | +$99.4K |
|
2064
Nuveen Quality Municipal Income Fund
NAD
$2.71B
| $217K | ﹤0.01% |
18,827
+6,050
| +47% | +$70K |
|
2065
Amplify Blockchain Technology ETF
BLOK
$1.1B
| $216K | ﹤0.01% |
11,185
-787
| -7% | -$14.3K |
|
2066
Novanta
NOVT
$5.04B
| $216K | ﹤0.01% |
+1,360
| New | +$209K |
|
2067
LCI Industries
LCII
$2.51B
| $216K | ﹤0.01% |
+1,967
| New | +$215K |
|
2068
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.83B
| $216K | ﹤0.01% |
+2,711
| New | +$214K |
|
2069
Equity Lifestyle Properties
ELS
$12.8B
| $216K | ﹤0.01% |
+3,215
| New | +$218K |
|
2070
BancFirst
BANF
$3.92B
| $215K | ﹤0.01% |
2,591
-189
| -7% | -$16.3K |
|
2071
Fox Factory Holding Corp
FOXF
$776M
| $215K | ﹤0.01% |
+1,772
| New | +$203K |
|
|
AMED
2072
DELISTED
Amedisys
AMED
| $215K | ﹤0.01% |
2,923
+262
| +10% | +$22.7K |
|
2073
VirTra
VTSI
$35.8M
| $215K | ﹤0.01% |
53,255
+755
| +1% | +$3.4K |
|
2074
Bank of Hawaii
BOH
$3.33B
| $215K | ﹤0.01% |
4,120
+1,235
| +43% | +$86.7K |
|
|
HTD
2075
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$924M
| $214K | ﹤0.01% |
+10,056
| New | +$231K |
|
Similar funds
Creative Planning's Q1 2023 Portfolio in Review
As of Q1 2023, Creative Planning held 2,836 positions worth $69.4B, up 4.4% from $66.5B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Creative Planning's Q1 2023 filing shows 350 new, 1,175 increased, 974 reduced and 190 closed positions. Its largest new stake was GE HealthCare: 49,973 shares worth $4.1M. The largest sale was iShares Core MSCI International Developed Markets ETF, an estimated $172M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4% a quarter earlier, followed by Financials and Healthcare.
- Creative Planning's largest Q1 2023 buy was GE HealthCare: 49,973 shares worth $4.1M.
- Creative Planning added most to Vanguard Total Bond Market in Q1 2023, an estimated $195M increase.
- Creative Planning's biggest Q1 2023 reduction was iShares Core MSCI International Developed Markets ETF, cutting an estimated $172M.
- Creative Planning fully exited Signify Health, Inc. in Q1 2023, selling an estimated $1.88M.
- Creative Planning's ten largest holdings make up 44% of its $69.4B portfolio in Q1 2023.
- Creative Planning opened 350 new positions and closed 190 in Q1 2023.
- Creative Planning's portfolio value rose 4.4% quarter-over-quarter to $69.4B.
Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.